Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年3月30日
	新闻
	Single-drug treatments are giving way to combination therapy for lung cancer Medical Xpress Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means treating a ... 标记为不相关
	Nivolumab-Based Treatment Yields Long-Term Survival in Resectable NSCLC CancerNetwork ... Lung Cancer Congress. 1. After a median follow-up of 50.5 months, the event-free survival (EFS) and overall survival (OS) rates across the intent ... 标记为不相关
	Vaping Likely Causes Cancer, Major Study Finds : ScienceAlert Science Alert Nicotine vaping is likely to cause lung and oral cancers, a comprehensive review of more than 100 studies has concluded. 标记为不相关
	Two Major Cancer Centers Announce Appointments of New Directors - The ASCO Post The ASCO Post Dr. Herbst has helped shape modern cancer research as the founding principal investigator of the National Cancer Institute–funded Yale SPORE in Lung ... 标记为不相关
	A review of studies warns of the carcinogenic potential of nicotine-containing e-cigarettes Science Media Centre España ... lung cancer. ... It reveals that there are already several studies linking e-cigarettes to oral cancer and presents the first studies on lung cancer. 标记为不相关
	UH Biology Student Awarded Prestigious Barry Goldwater Scholarship University of Houston ... cancer immunotherapies, initially focusing on lung cancer. His recruitment is supported by the Cancer Prevention and Research Institute of Texas. 标记为不相关
	Combining Immunotherapy With Fungal Therapeutics: The Future of Treatment? Contagion Live Jatin Vyas, PhD, MD, discusses where the research is headed as it takes a page from the oncology world in trying to harness the immune system and ... 标记为不相关
	The Evolution of Frontline Therapy in EGFR-Mutant NSCLC | OncLive OncLive ... lung cancer (NSCLC). Villanueva highlights the impact of the FLAURA ... Breast Cancer Tumor Board: Targeting TROP2 – Innovations in Triple-Negative ... 标记为不相关
	Microbubbles - Works in Progress Magazine Works in Progress In many cases, less than one percent of an injected cancer drug dose actually reaches the tumor. ... lung cancers, as they can more easily permeate ... 标记为不相关
	How AI is Revolutionizing Clinical Trials - Immunotherapy, Biomarkers, and Cancer Pathways Targeted Oncology Expect implications for maximizing outcomes with targeted therapies in neoadjuvant settings. ... Big Shifts Ahead in Lung Cancer: New KRAS Data and ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈